Building Characterization Assays to Support Early-Stage saRNA Development and QC Alignment

2:30 pm - Thursday 26th February 2026

  • Establishing characterization assays that define saRNA product quality and inform key CMC decisions in early development.
  • Ensuring analytical consistency and data integrity when partnering with CROs and CDMOs for assay execution and method transfer.

Speakers:

Senior Scientist
Immunomic Therapeutics